This activity has expired. Credit is no longer available.
This activity is supported by unrestricted educational grants from Celgene Corporation and Takeda Oncology.

Risk Stratification in Multiple Myeloma: Putting the Pieces Together

Hans Lee, MD
The University of Texas MD Anderson Cancer Center

Tiffany A. Richards, PhD, ANP, AOCNP®
The University of Texas MD Anderson Cancer Center

While the past few years have shown an unprecedented increase in the number of agents available to treat patients with multiple myeloma, many advanced practitioners struggle with optimal agent choice, timing, and sequencing, especially related to the use of these newer agents in combination regimens. Learn about these aspects of treatment, as well as testing and diagnosis, risk stratification, emerging toxicities, and supporting patients on oral therapies.


Download Transcript


Download Slides


These activities, certified for CME/CE/CPE credit, are jointly provided by

Annenberg Logo Harborside Press Logo
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.